Simone Tambaro

May 31, 2023

The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice

Abstract Simple Summary: Alzheimer’s disease (AD) is a complex, multifactorial disease where numerous components, such as environment, lifestyle, comorbidities, and…

April 15, 2022

Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

Abstract Emotional behavior, memory, and learning have been associated with alterations in the immune system in neuropsychiatric and neurodegenerative diseases.…

June 17, 2021

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

Abstract Simple Summary: This review was aimed at exploring the potentiality of drugging the endocannabinoid system as a therapeutic option…

August 26, 2010

Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis

Abstract Cogent evidence shows that cannabis plays a variable role on behavioral regulation and the pathophysiology of most psychiatric conditions.…